Your browser doesn't support javascript.
loading
RELEVENT Trial: Phase II Trial of Ramucirumab, Carboplatin, and Paclitaxel in Previously Untreated Thymic Carcinoma/B3 Thymoma With Area of Carcinoma.
Imbimbo, Martina; Vitali, Milena; Fabbri, Alessandra; Ottaviano, Margaret; Pasello, Giulia; Petrini, Iacopo; Palmieri, Giovannella; Berardi, Rossana; Zucali, Paolo; Ganzinelli, Monica; Marabese, Mirko; Broggini, Massimo; Marino, Mirella; Trama, Annalisa; Rulli, Eliana; Hollander, Lital; Pruneri, Giancarlo; Torri, Valter; Garassino, Marina Chiara.
Affiliation
  • Imbimbo M; Unit of Thoracic Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: martina.imbimbo@istitutotumori.mi.it.
  • Vitali M; Unit of Thoracic Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Fabbri A; Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Ottaviano M; Rare Tumors Reference Center, Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy.
  • Pasello G; Department of Medical Oncology 2, Istituto Oncologico Veneto IRCCS Padova, Padua, Italy.
  • Petrini I; Division of General Pathology, Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy.
  • Palmieri G; Rare Tumors Reference Center, Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy.
  • Berardi R; Oncology Clinic, Università Politecnica delle Marche, Ospedali Riuniti di Ancona, Ancona, Italy.
  • Zucali P; Department of Medical Oncology, Humanitas Clinical and Research Hospital, Rozzano, Milan, Italy.
  • Ganzinelli M; Unit of Thoracic Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Marabese M; Laboratory of Molecular Pharmacology, Department of Oncology, IRCCS Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy.
  • Broggini M; Laboratory of Molecular Pharmacology, Department of Oncology, IRCCS Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy.
  • Marino M; Department of Pathology, Regina Elena National Cancer Institute, Rome, Italy.
  • Trama A; Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Rulli E; Laboratory of Methodology for Biomedical Research, IRCCS Mario Negri Institute for Pharmacological Research, Milan, Italy.
  • Hollander L; Laboratory of Methodology for Biomedical Research, IRCCS Mario Negri Institute for Pharmacological Research, Milan, Italy.
  • Pruneri G; Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Torri V; Laboratory of Methodology for Biomedical Research, IRCCS Mario Negri Institute for Pharmacological Research, Milan, Italy.
  • Garassino MC; Unit of Thoracic Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Clin Lung Cancer ; 19(5): e811-e814, 2018 09.
Article in En | MEDLINE | ID: mdl-30033090
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Research Design / Thymoma / Thymus Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Clin Lung Cancer Journal subject: NEOPLASIAS Year: 2018 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Research Design / Thymoma / Thymus Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Clin Lung Cancer Journal subject: NEOPLASIAS Year: 2018 Document type: Article Country of publication: United States